standard]
MMTTTRISPAWPLLLITLVYVVYMGDRPKGEFSATAQHMSMLQATIGSKR
ASESWLYSYKRSFNGFVAKLTEEEKTKIASLEGVVSVFPSTKKQLHTTRS
WDFMGFPVAAERTKTESDVIVGMLDTGIWPESPSFDDKDFGAPPTKWKGT
CQSSSNFTCNNKIIGARYYHSEGTISPPDFPSPRDSEGHGSHTASTAAGG
LVYGANLYGLGAGTARGGVPSARIAVYKICWSDGCSDADILAAFDDAIAD
GVDIISISVGGFFPSDYFADPIAIGAFHAMKNGVLTSNSAGNSGPDSASI
VNFSPWSLSVAASTIDRKFLTNVQLGNNESYVGVSVNTFVLENESYPLVY
GGNVPNTAGGYDNSTSRYCEFDSLDPKLVEGTIVLCDGLNDAEPATVAGA
AGTIMHDDYFRDFAFSFPLPASYLGNDDGDKVHGYINGTSKPTATIFKSV
EVNDTLAPFVVSFSSRGPNPITADLLKPDLTAPGVDILAAWSEATTVTGY
PDDPRVVPYNIISGTSMSCPHASGAAAYVKSFNPTWSPSAIKSALMTTAA
SMRVATNTDAEFAYGSGHIDPLKAKSPGLVYDIEEADYVSFLCGQGYSNK
NLQLITGDNTTCTASNNATVYDLNYPSFTLSAASGASISRVFHRTVTNVG
SASSTYRAAVVAPPALSIQVQPSILSFKSVGEKQSFAVTVTASVDESVLS
ASLVWDDGEYKVRSPVVAYAA
|
IPR000209; Peptidase S8/S53, subtilisin/kexin/sedolisin IPR003137; Protease-associated domain, PA IPR010259; Proteinase inhibitor I9, subtilisin propeptide IPR022398; Peptidase S8/S53, subtilisin, act |